The Role of Cannabis within an Emerging Perspective on Schizophrenia

The Role of Cannabis within an Emerging Perspective on Schizophrenia

Background: Approximately 0.5% of the population is diagnosed with some form of schizophrenia, under the prevailing view that the pathology is best treated using pharmaceutical medications that act on monoamine receptors. Methods: We briefly review evidence on the impact of environmental forces, par...

Full description

Bibliographic Details
Main Authors: Jegason P. Diviant, Jacob M. Vigil, Sarah S. Stith
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Medicines
Subjects:
schizophrenia
cannabis
marijuana
autoimmunity
monoamine therapy
mental illness
cannabidiol
tetrahydrocannabinol
endocannabinoid system
Online Access:http://www.mdpi.com/2305-6320/5/3/86

Internet

http://www.mdpi.com/2305-6320/5/3/86

Similar Items